Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

Quattrone, Diego
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.532
EU - Europa 3.534
AS - Asia 2.846
Continente sconosciuto - Info sul continente non disponibili 843
SA - Sud America 486
AF - Africa 98
OC - Oceania 15
Totale 13.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.344
IT - Italia 1.103
SG - Singapore 1.044
RU - Federazione Russa 881
CN - Cina 616
DE - Germania 543
BR - Brasile 375
HK - Hong Kong 315
BD - Bangladesh 227
PL - Polonia 225
VN - Vietnam 219
FR - Francia 180
GB - Regno Unito 168
JP - Giappone 96
FI - Finlandia 93
CA - Canada 89
NL - Olanda 61
IN - India 57
IE - Irlanda 52
KR - Corea 42
AT - Austria 38
ES - Italia 38
TR - Turchia 38
SE - Svezia 34
IQ - Iraq 32
AR - Argentina 31
MX - Messico 31
RO - Romania 31
CI - Costa d'Avorio 21
ZA - Sudafrica 21
ID - Indonesia 17
UA - Ucraina 17
CL - Cile 15
CR - Costa Rica 15
EC - Ecuador 15
JM - Giamaica 15
VE - Venezuela 15
AU - Australia 14
BE - Belgio 14
MY - Malesia 14
SA - Arabia Saudita 14
PK - Pakistan 13
TW - Taiwan 13
CO - Colombia 12
KE - Kenya 12
UZ - Uzbekistan 12
GR - Grecia 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
EG - Egitto 10
MA - Marocco 10
PY - Paraguay 10
IR - Iran 9
PH - Filippine 9
HN - Honduras 7
KZ - Kazakistan 6
LT - Lituania 6
TN - Tunisia 6
AL - Albania 5
NI - Nicaragua 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BG - Bulgaria 4
BO - Bolivia 4
PE - Perù 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EU - Europa 3
IL - Israele 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
SV - El Salvador 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
NE - Niger 2
PA - Panama 2
SN - Senegal 2
TH - Thailandia 2
AO - Angola 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CG - Congo 1
ET - Etiopia 1
Totale 12.494
Salva come PNG Salva come JPEG
Città #
Ashburn 709
Singapore 695
San Jose 562
Fairfield 460
Hong Kong 293
Palermo 254
Chandler 225
Zgierz 206
Woodbridge 196
Houston 192
Wilmington 160
Seattle 159
Dallas 158
Council Bluffs 152
Los Angeles 132
Ann Arbor 126
Cambridge 126
Moscow 122
Hefei 110
Beijing 105
Lauterbourg 91
Tokyo 85
Ho Chi Minh City 84
New York 82
Medford 78
Rome 78
Boardman 74
Lappeenranta 66
Chicago 58
Buffalo 57
Santa Clara 54
Milan 53
Dublin 49
Hanoi 49
Des Moines 48
The Dalles 48
Altamura 45
Princeton 45
Lawrence 41
London 40
San Diego 36
Nuremberg 35
São Paulo 31
Frankfurt am Main 30
Seoul 29
Atlanta 27
Ludwigshafen am Rhein 27
Brooklyn 26
Orem 25
Helsinki 24
Abidjan 21
Naples 21
Amsterdam 20
Montreal 20
Phoenix 20
Toronto 18
Columbus 17
Florence 16
Johannesburg 16
Redwood City 15
Rio de Janeiro 15
Alimena 14
Paris 14
Vienna 14
Bologna 13
Dearborn 13
Denver 13
Falls Church 13
Nanjing 13
Salt Lake City 13
San Paolo di Civitate 13
Warsaw 13
Washington 13
San Francisco 12
Istanbul 11
Kingston 11
Manchester 11
Messina 11
Tower Hamlets 11
Boston 10
Brussels 10
Central 10
Erbil 10
Melbourne 10
Mexico City 10
Redondo Beach 10
Shanghai 10
Tashkent 10
Amman 9
Baghdad 9
Bari 9
Catania 9
Chennai 9
Da Nang 9
Elk Grove Village 9
Munich 9
Nairobi 9
Philadelphia 9
Turin 9
Haiphong 8
Totale 7.279
Salva come PNG Salva come JPEG
Nome #
Interplay Between Childhood Maltreatment, Subclinical Post-Traumatic Stress Symptoms, and IQ: Findings From the EU-GEI Multicentre Case–Control Study 435
Neurobiological and Anti-Inflammatory Effects of a Deep Diaphragmatic Breathing Technique Based on Neofunctional Psychotherapy: A Pilot RCT 285
Treated incidence of psychotic disorders in the multinational EU-GEI study 277
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU GEI study 271
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study 267
Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study 253
Prevalence and Risk Factors for Internet Gaming Disorder (IGD) in a sample of 5,979 Italian Online Gamers 250
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 246
Differences between female and male gamers and gender-specific risk-factors for internet gaming disorder (IGD) 246
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use 239
DOES POLYGENIC RISK SCORE FOR SCHIZOPHRENIA IMPACT ON JUMPING TO CONCLUSIONS? PRELIMINARY FINDINGS FROM THE EU-GEI CASE-CONTROL STUDY 229
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls 228
Risk factors for internet gaming disorder in a sample of 5,979 italian online gamers. 227
BIOLOGICAL AND EPIDEMIOLOGICAL EXAMINATION OF TRANSDIAGNOSTIC AND SPECIFIC SYMPTOM DIMENSIONS AT PSYCHOSIS ONSET: FINDINGS FROM THE EUGEI STUDY 222
Psychological distress and suicidal ideation in Sicilian Medical Students: The SMS-ME project 219
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study 219
Are Polygenic Risk Scores for Major Mental Disorders Associated with General or Specific Psychosis Symptom dimensions? 215
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 208
F115POLYGENIC RISK SCORES FOR SCHIZOPHRENIA, BIPOLAR, AND MAJOR DEPRESSIVE DISORDERS PREDICT TRANSDIAGNOSTIC SYMPTOM DIMENSIONS AT FIRST EPISODE PSYCHOSIS 206
IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use. 195
What does augment the risk to use cannabis on an everyday-basis in psychotic patients? 190
Beyond the Gender Binarism: Neural Correlates of Trans Men in a Functional Connectivity–Resting-State fMRI Pilot Study 187
O4.8. CAN YOU SPOT EMOTIONS? FACIAL EMOTION RECOGNITION AND GENETIC RISK FOR PSYCHOSIS 187
FIRST EPISODE PSYCHOTIC PATIENTS WITH A HISTORY OF FREQUENT CANNABIS USE EXPRESS MORE POSITIVE SYMPTOMS AT ILLNESS ONSET THAN THOSE WHO NEVER USED CANNABIS 183
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia 183
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings 176
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme 174
DOES CANNABIS USE WORSEN PSYCHOTIC SYMPTOM PRESENTATION? 167
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study 166
FIRST EPISODE PSYCHOSIS PATIENTS WHO USED CANNABIS DEVELOP THEIR ILLNESS AT A SIGNIFICANTLY YOUNGER AGE THAN THOSE WHO NEVER USED CONSISTENTLY ACROSS EUROPE AND BRAZIL 155
COGNITION, METACOGNITION AND SOCIAL COGNITION AFTER A FIRST EPISODE PSYCHOSIS. PRELIMINARY RESULTS FROM A 5-YEAR-FOLLOW-UP STUDY 148
Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: Results from the EU-GEI case-control study 147
O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS 145
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study 139
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IMPAIRMENT IN FIRST EPISODE PSYCHOSIS ACROSS EUROPE 138
IS THE ERA OF CANDIDATE GENES X CANNABIS USE REALLY DEAD? 135
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI) 133
BEHAVIOURAL PREDICTORS OF WEIGHT LOSS MAINTENANCE AFTER BARIATRIC SURGERY: A SCOPING REVIEW 132
T42. JUMPING TO CONCLUSIONS IS ASSOCIATED WITH THE POLYGENIC RISK SCORE FOR INTELLIGENCE BUT NOT FOR SCHIZOPHRENIA. PRELIMINARY FINDINGS FROM THE EU-GEI STUDY 131
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors 129
SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE 127
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study 125
The incidence of psychotic disorders among migrants and minority ethnic groups in Europe: Findings from the multinational EU-GEI study 124
FIRST EPISODE PSYCHOSIS PATIENTS ACROSS EUROPE DIFFER IN INTELLECTUAL QUOTIENT (IQ) AND EXPOSURE TO ENVIRONMENTAL HAZARDS 118
Tobacco use in first-episode psychosis, a multinational EU-GEI study 112
35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS 112
JUMPING TO CONCLUSIONS AND FACIAL EMOTION RECOGNITION IN FIRST-EPISODE PSYCHOSIS: LONGITUDINAL INSIGHTS FROM THE GAP FOLLOW-UP STUDY 112
A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders 108
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data 106
Migration history and risk of psychosis: Results from the multinational EU-GEI study 106
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings 105
Genetics for mental health clinicians: a call for a globally accessible and equitable psychiatric genetics education 101
EXPLORING SPECIFIC EFFECTS OF TYPE AND TIMING OF EXPOSURE TO CHILDHOOD ADVERSITY AND SYMPTOM DOMAINS IN FIRST EPISODE OF PSYCHOSIS: PRELIMINARY RESULTS FROM THE EUGEI PROJECT 101
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study 97
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study 97
Pre-training inter-rater reliability of clinical instruments in an international psychosis research project 97
58.1 Cannabis use Across Europe: A Ticket to Psychosis? 96
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 95
P.0170 Distinct polygenic risk scores in clusters of psychotic subjects with different premorbid trajectories and current IQ 95
Mapping genomic loci implicates genes and synaptic biology in schizophrenia 94
Abnormal illness behavior and Internet addiction severity: The role of disease conviction, irritability, and alexithymia 93
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study 93
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study 92
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 91
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study 91
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 90
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 89
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study 86
ENVIRONMENTAL RISK FACTORS DIFFERENCES AMONG DIAGNOSTIC CATEGORIES IN EU-GEI STUDY 83
Early parental death and risk of psychosis in offspring: A six-country case-control study 82
P.0171 The independent and joint effect of the endocannabinoid system and daily cannabis use on the risk of psychosis 79
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study 78
Methylomic signature of current cannabis use in two first-episode psychosis cohorts 77
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis 75
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis 75
The Kraepelian concept of schizophrenia: Dying but not yet dead 75
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study 72
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 72
Duration of Untreated Psychosis in First-Episode Psychosis is not Associated with Common Genetic Variants for Major Psychiatric Conditions: Results from the Multi-Center EU-GEI Study 72
SA11DO PRS FOR SQUIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION DISTINGUISH BETWEEN AFFECTIVE-PSYCHOSIS DIAGNOSTIC CATEGORIES? THE EUGEI STUDY 71
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study 71
Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis 70
SU132CANNABIS USE AND SCHIZOPHRENIA: CAN GENETICS TELL IF IS IT "THE CHICKEN OR THE EGG"? 70
The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study 70
Unraveling Exercise Addiction: The Role of Narcissism and Self-Esteem 69
Differential gene expression analysis in blood of first episode psychosis patients 68
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies 66
Novel psychoactive substances and induced phenomena in psychopathology: The lysergic psychoma 64
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 64
W73. GENETIC AND SOCIOENVIROMENTAL CORRELATES OF SYMPTOM DIMENSIONS ACROSS THE PSYCHOSIS SPECTRUM AT BASELINE AND 10-YEAR FOLLOW-UP 62
The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use 59
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 58
Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study 57
Letter to the editor: Is polygenic risk for Parkinson's disease associated with less risk of first episode psychosis? 55
The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe 54
Novel psychoactive substances in young adults with and without psychiatric comorbidities 53
Do Idiopathic Parkinson's Disease and Schizophrenia Lie on the Same Genetic Spectrum? 53
Substance-induced psychosis and schizophrenia: the interaction point 51
Does personality matter? Temperament and character dimensions in panic subtypes 50
First-generation antipsychotics and QTc: any role for mediating variables? 50
Totale 13.060
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022683 0 93 30 34 34 67 28 110 58 62 61 106
2022/2023852 82 151 32 58 82 149 60 52 92 16 61 17
2023/2024773 14 50 17 79 46 58 89 33 1 54 38 294
2024/20251.944 167 80 82 157 81 76 158 147 172 220 213 391
2025/20266.299 367 194 486 840 556 690 850 650 501 394 429 342
2026/2027729 434 295 0 0 0 0 0 0 0 0 0 0
Totale 13.354